Skip to main content
. 2019 Mar 20;9:119. doi: 10.3389/fonc.2019.00119

Table 5.

Hotspot mutation detection.

Patient Gene AA change AD AN (AF)a AD TM (AF)b LVJ ANR CHLc Cosmic count
BHH01 PIK3CA H1047R 473,9 (0.02) 378,201 (0.35) Yes LQCd 3 1,806
HHP13 PIK3CA E545K 332,0 (0) 195,11 (0.05) No Yes 3 332
BHH06 AKT1 E17K 121,23 (0.16) 151,62 (0.29) Yes No 3 295
BHH24 AKT1 E17K 123,1 (0.01) 118,60 (0.34) Yes Yes 3 295
BHH28 PIK3CA H1047L 417,0 (0) 348,81 (0.19) Yes Yes 3 262
HHP19 TP53 G245S 186,1 (0.01) 61,76 (0.55) Yes Yes 3 81
BHH18 PIK3CA Q546E 201,16 (0.07) 164,38 (0.19) Yes No 3 3
BHH18 PIK3CA G106R 127,8 (0.06) 96,19 (0.17) Yes No 3 2
BHH25 PIK3CA E726K 269,0 (0) 268,17 (0.06) No Yes 2 31
BHH25 SF3B1 K666E 210,0 (0) 122,46 (0.27) Yes Yes 2 19
a

Allelic depth of reads supporting the reference, alternate alleles in the adjacent normal sample.

b

Tumor sample.

c

Cancer hotspots database validation level (Cancer Hotspots).

d

Called by one of three paired somatic variant callers (strelka).